Introduction {#s1}
============

Electrocardiogram plays a fundamental role in the diagnosis and risk-stratification in patients with acute myocardial infarction. Acute myocardial infarction due to a culprit lesion in the left anterior descending (LAD) artery, which supplies a large territory of the left ventricle, results in wide-spread myocardial injury leading to worse clinical outcomes \[[@R01], [@R02]\]. Therefore, it is crucial to promptly identify patients with LAD culprit lesion who are at an increased risk for adverse events.

Unlike in patients with ST-segment elevation myocardial infarction, the identification of the infarct-related artery is often challenging in non-ST-segment elevation acute coronary syndrome since the location of ST-segment changes generally does not correlate with infarct location. Nevertheless, the presence of either symmetrically inverted or biphasic T waves in anterior precordial leads, so-called Wellens' sign, has been reported to predict LAD culprit lesion in patients with unstable angina in the studies published almost 3 decades ago when sensitive biomarker cardiac troponin was not available \[[@R03]-[@R05]\]. Although it is assumed that some of the patients with unstable angina in these studies would have had troponin elevation and been diagnosed with non-ST-elevation myocardial infarction (NSTEMI) if cardiac troponin had been available, the prevalence of Wellens' sign and its predictive value for LAD culprit lesion have not been clarified in a contemporary NSTEMI cohort.

In this context, we aimed to evaluate the prevalence of Wellens' sign and its predictive value for LAD culprit lesion in patients with NSTEMI who underwent coronary angiography.

Materials and Methods {#s2}
=====================

We performed a retrospective analysis on 481 consecutive NSTEMI patients who underwent coronary angiography within 5 days from presentation between January 2013 and June 2014. Myocardial infarction was diagnosed in accordance with the European Society of Cardiology and American College of Cardiology criteria \[[@R06]\]. Inclusion criteria were: 1) Troponin I level greater than the 99th percentile reference value before cardiac catheterization; 2) Chest pain (or anginal equivalent) or ischemic change on electrocardiogram including horizontal or down-sloping ST-segment depression (≥ 0.05 mV) or T-wave inversion (≥ 0.10 mV) in two or more contiguous leads; and 3) The absence of ST-segment elevation on electrocardiogram. We excluded patients with complete bundle branch block (n = 49), those with ventricular paced rhythm (n = 8), those with electrocardiographic left ventricular hypertrophy (n = 99), and those with pathologic Q wave in leads V2 and V3 (n = 5). In addition, we excluded patients with history of coronary artery bypass grafting (CABG) (n = 31) since identification of the culprit lesion in those patients is often difficult. We also excluded patients with more than one presumed culprit lesions (n = 15).

The present study complied with the Declaration of Helsinki and was approved by the institutional review board.

Demographic, hemodynamic and laboratory data {#s2a}
--------------------------------------------

Electronic medical records were reviewed and following patients' demographic data such as age, gender, body mass index, history of hypertension, history of diabetes mellitus, history of hyperlipidemia, history of chronic kidney disease, personal and family history of coronary artery disease (CAD), current smoking status, and previous myocardial infarction were abstracted. Thrombolysis in myocardial infarction (TIMI) risk score was calculated and classified into three groups: low risk (0 - 2), intermediate risk (3 - 4), and high risk (5 - 7). Initial presenting vital signs such as systolic blood pressure, diastolic blood pressure, and heart rate were recorded. In addition, the presence of chest pain at emergency department was recorded.

Laboratory data on admission including white blood cell count, hemoglobin level, and estimated glomerular filtration rate (eGFR) were recorded. Cardiac troponin I was measured using the second-generation VITROS^®^ troponin I assay (Ortho-Clinical Diagnostics Inc., NJ, USA). The upper limit of normal for cardiac troponin I was 0.034 µg/L, which represented the 99th percentile reference value.

Transthoracic echocardiography was performed in a standard manner during hospitalization. Left ventricular ejection fraction was obtained using either the Teichholz or biplane Simpson's method.

Electrocardiogram {#s2b}
-----------------

Standard 12-lead electrocardiograms (25 mm/s and 10 mm = 1 mV) were obtained from all patients at the time of presentation to the emergency department and were reviewed by two independent reviewers in a blinded fashion. In the events of any discrepancy in the assessments, the two reviewers reached a consensus through discussion.

Wellens' sign was present when there are either symmetrically inverted T waves (≥ 0.10 mV) or biphasic T waves in both leads V2 and V3 along with previous studies \[[@R03], [@R04]\]. Example electrocardiograms with symmetrically inverted T waves (≥ 0.10 mV) ([Fig. 1a](#F1){ref-type="fig"}) and biphasic T waves in both leads V2 and V3 ([Fig. 1b](#F1){ref-type="fig"}) are presented in [Figure 1](#F1){ref-type="fig"}. In patients with symmetrically inverted T waves, a depth of T-wave inversion was measured from T-P segment as the baseline. ST-segment deviations were measured at the J point. ST-segment depression ≥ 0.05 mV in more than two contiguous leads was recorded. The cut-off of ≥ 0.05 mV was chosen in line with current universal definition of myocardial infarction \[[@R06]\]. The location of ST-segment depression was recorded as anterior (V1 - V4), lateral (I, aVL,V5, and V6), and inferior (II, III, and aVF).

![Electrocardiograms with symmetrically inverted T waves (≥ 0.10 mV) (Fig. 1a) and biphasic T waves in both leads V2 and V3 (Fig. 1b).](cr-10-135-g001){#F1}

Left ventricular hypertrophy defined by Sokolow-Lyon voltage amplitude criteria S~V1~ + R~V5\ or\ V6~ ≥ 3.5 mV and Cornell voltage criteria S~V3~ + R~aVL~ ≥ 2.8 mV in men and ≥ 2.0 mV in women \[[@R07], [@R08]\]. In patients with left anterior hemi-block, left ventricular hypertrophy was defined by S~III~ + maximal precordial R + S ≥ 3.0 mV \[[@R9]\].

Coronary angiography {#s2c}
--------------------

All patients underwent coronary angiography within 5 days from presentation. An independent cardiologist blinded to the clinical data reviewed all coronary angiography, and the assessment was compared to the primary assessment by the treating cardiologist. In the event of a discrepancy between the assessments, a third investigator made the final interpretation. Obstructive CAD was defined as stenosis ≥ 50% in the left main coronary artery and ≥ 70% in any other epicardial coronary arteries. The culprit lesion was determined based on the echocardiographic and angiographic findings including previous coronary angiography, if available. Proximal LAD artery was defined as that proximal to the first septal branch. Revascularization procedures including percutaneous coronary intervention (PCI) and CABG were performed at the discretion of the treating physician. In addition, coronary blood flow was graded according to TIMI criteria \[[@R10]\].

End points {#s2d}
----------

The primary end point was the prevalence of LAD culprit. In addition, in-hospital mortality and recurrent myocardial infarction were recorded.

Statistic analyses {#s2e}
------------------

Data was expressed as either a number (percentage) or median (interquartile range). Continuous variables were compared using the Wilcoxon rank sum test. Dichotomous variables were compared using the Chi-square test or Fisher's exact test. Two-sided P values \< 0.05 were considered statistically significant. All statistical analyses were performed using R software (version 3.0.1).

Results {#s3}
=======

Baseline, hemodynamic, and laboratory data {#s3a}
------------------------------------------

After excluding 207 patients who met the exclusion criteria, a total of 274 patients with NSTEMI who underwent coronary angiography were included, of whom 24 patients (8.8%) had Wellens' sign. Baseline demographic and clinical characteristics are summarized in [Table 1](#T1){ref-type="table"}. Baseline clinical characteristics are comparable between patients with or without Wellens' sign except for that patients with Wellens' sign were more likely to be female. Majority of patients with or without Wellens' sign had chest pain at emergency department. Patients with Wellens' sign had a lower left ventricular ejection fraction than those without it, whereas peak troponin I values were comparable between the two groups.

###### Demographic, Hemodynamic, and Laboratory Characteristics of Patients With and Without Wellens' Sign

                                                      Wellens' sign (n = 24)   Control (n = 250)    P value
  --------------------------------------------------- ------------------------ -------------------- ---------
  Demographics                                                                                      
    Age (years)                                       68 (58 - 79)             64 (55 - 72)         0.24
    Female                                            15 (62.5)                97 (38.8)            0.024
    Body mass index (kg/m^2^)                         26.3 (24.6 - 28.9)       27.5 (24.1 - 30.8)   0.24
    Hypertension                                      15 (62.5)                177 (70.8)           0.4
    Diabetes mellitus                                 6 (25.0)                 82 (32.8)            0.43
    Hyperlipidemia                                    10 (41.7)                141 (56.4)           0.17
    Chronic kidney disease                            7 (29.2)                 59 (23.6)            0.54
    History of coronary artery disease                6 (25.0)                 50 (20.0)            0.56
    Family history of coronary artery disease         3 (12.5)                 61 (24.4)            0.31
    Current smoker                                    4 (16.7)                 68 (27.2)            0.26
    Previous myocardial infarction                    1 (4.2)                  31 (12.4)            0.33
  Thrombolysis in myocardial infarction risk score                                                  
    Low risk (0 - 2)                                  8 (33.3)                 54 (21.6)            0.47
    Intermediate risk (3 - 4)                         12 (50.0)                147 (58.8)           0.47
    High risk (5 - 7)                                 4 (16.7)                 49 (19.6)            0.47
  Symptom, presence of chest pain at emergency room   19 (79.2)                219 (87.6)           0.22
  Hemodynamic and laboratory data                                                                   
    Systolic blood pressure (mm Hg)                   141 (122 - 159)          140 (123 - 156)      0.78
    Diastolic blood pressure (mm Hg)                  76 (73 - 98)             80 (72 - 91)         0.77
    Heart rate (beat/min)                             82 (64 - 88)             75 (66 - 89)         0.85
    Hemoglobin (g/L)                                  13.0 (12.1 - 14.3)       13.5 (12.2 - 14.5)   0.45
    White blood cell count (10^9^/L)                  8.2 (6.9 - 11.0)         8.5 (6.7 - 10.3)     0.83
    eGFR (mL/min/1.73 m^2^)                           69 (54 - 88)             80 (61 - 93)         0.19
    Elevated first troponin                           22 (91.7)                212 (84.8)           0.54
    Peak troponin I (µg/L)                            0.67 (0.11 - 4.36)       0.94 (0.14 - 6.45)   0.33
  Killip class on admission                                                                         
    Killip class I on admission                       21 (87.5)                229 (91.6)           0.094
    Killip class II on admission                      1 (4.2)                  18 (7.2)             0.094
    Killip class III on admission                     1 (4.2)                  2 (0.8)              0.094
    Killip class IV on admission                      1 (4.2)                  1 (0.4)              0.094
  Left ventricular ejection fraction (%)              53 (45 - 60)             60 (55 - 65)         0.013

Data are expressed as a number (percent) or median (interquartile range). eGFR: estimated glomerular filtration rate.

Electrocardiographic characteristics {#s3b}
------------------------------------

Electrocardiographic characteristics are summarized and presented in [Table 2](#T2){ref-type="table"}. Among the 24 patients with Wellens' sign, 10 patients had biphasic T waves in both leads V2 and V3, and 14 patients had symmetrically inverted T waves (≥ 0.10 mV) in both leads V2 and V3. Among the 14 patients with symmetric T-wave inversion, 11 had T-wave inversion (≥ 0.20 mV) and four had T-wave inversion (≥ 0.30 mV) in both leads V2 and V3. Among the 24 patients with Wellens' sign, 14 patients had similar T-wave abnormalities in lead V1, 18 patients in lead V4, 12 patients in lead V5, and eight patients in lead V6. Patients with Wellens' sign were less likely to have concomitant ST depression.

###### Electrocardiographic Characteristics of Patients With and Without Wellens' Sign

                                                                     Wellens' sign (n = 24)   Control (n = 250)   P value
  ------------------------------------------------------------------ ------------------------ ------------------- ----------
  Heart rate (beat/min)                                              81 (73 - 95)             79 (71 - 92)        0.74
  Atrial fibrillation                                                2 (8.3)                  7 (2.8)             0.18
  Biphasic T wave at leads V2 and V3                                 10 (41.7)                0 (0.0)             \< 0.001
  Symmetrically inverted T wave (≥ 0.10 mV) in leads V2 and V3       14 (58.3)                0 (0.0)             \< 0.001
  Symmetrically inverted T wave (≥ 0.20 mV) in leads V2 and V3       11 (45.8)                0 (0.0)             \< 0.001
  Symmetrically inverted T wave (≥ 0.30 mV) in leads V2 and V3       4 (16.7)                 0 (0.0)             \< 0.001
  Biphasic or symmetrically inverted T wave (≥ 0.10 mV) in lead V1   14 (58.3)                71 (28.4)           0.002
  Biphasic or symmetrically inverted T wave (≥ 0.10 mV) in lead V4   18 (75.0)                25 (10.0)           \< 0.001
  Biphasic or symmetrically inverted T wave (≥ 0.10 mV) in lead V5   12 (50.0)                30 (12.0)           \< 0.001
  Biphasic or symmetrically inverted T wave (≥ 0.10 mV) in lead V6   8 (33.3)                 27 (10.8)           0.005
  ST segment depression (≥ 0.05 mV)                                  1 (4.2)                  81 (32.4)           0.004
  Anterior ST depression (V1 - V4)                                   1 (4.2)                  27 (10.8)           0.49
  Lateral ST depression (I, aVL,V5, and V6)                          1 (4.2)                  67 (26.8)           0.014
  Inferior ST depression (II, III, and aVF)                          0 (0.0)                  35 (14.0)           0.053

Data are expressed as a number (percent) or median (interquartile range).

The sensitivity and specificity of electrocardiographic findings predicting for LAD culprit are presented in [Table 3](#T3){ref-type="table"}. Wellen's sign (presence of either symmetrically inverted T waves (≥ 0.10 mV) or biphasic T waves in both leads V2 and V3) had a sensitivity of 24.6% and a specificity of 96.2% for LAD culprit lesion. Biphasic T waves in both leads V2 and V3 had a sensitivity of 12.3% and a specificity of 99.0%. Symmetric T-wave inversion (≥ 0.10 mV) in both leads V2 and V3 had a sensitivity of 12.3% and a specificity of 97.1%. As the cut-off of T-wave inversion increases, a sensitivity fell to 9.2% for T-wave inversion (≥ 0.20 mV) and 3.1% for T-wave inversion (≥ 0.30 mV) with specificity of 97.6% for T-wave inversion (≥ 0.20 mV) and 99.0% for T-wave inversion (≥ 0.30 mV), respectively.

###### Predictive Values of Wellens' Sign, Either Symmetrically Inverted T Waves (≥ 0.10 mV) or Biphasic T Waves in Both Leads V2 and V3, for Left Anterior Descending Artery Culprit

                                                                                    Sensitivity   Specificity   PPV      NPV      Accuracy
  --------------------------------------------------------------------------------- ------------- ------------- -------- -------- ----------
  Biphasic T wave in leads V2 and V3                                                12.30%        99.00%        80.00%   78.40%   78.50%
  Symmetrically inverted T wave (≥ 0.10 mV) in leads V2 and V3                      12.30%        97.10%        57.10%   78.10%   77.00%
  Symmetrically inverted T wave (≥ 0.20 mV) in leads V2 and V3                      9.20%         97.60%        54.50%   77.60%   76.70%
  Symmetrically inverted T wave (≥ 0.30 mV) in leads V2 and V3                      3.10%         99.00%        50%      76.70%   76.30%
  Either biphasic or symmetrically inverted T wave (≥ 0.10 mV) in leads V2 and V3   24.60%        96.20%        66.70%   80.40%   79.20%

PPV: positive predictive value; NPV: negative predictive value.

Angiographic characteristics and revascularization procedures {#s3c}
-------------------------------------------------------------

Angiographic characteristics are presented in [Table 4](#T4){ref-type="table"}. Among the 24 patients with Wellens' sign, 16 patients had a LAD culprit (eight proximal and eight mid LAD), two had a non-LAD culprit (circumflex lesions), and six had non-obstructive CAD. Patients with Wellens' sign were more likely to have LAD culprit compared to those without it (66.7% vs. 19.6%, P \< 0.001). Among the 16 patients with Wellens' sign and LAD culprit, one patient had 100% occlusion, seven patients had 99% stenosis, five patients had 90% stenosis, and three patients had 75% stenosis. Patients with Wellens' sign were less likely to have pre-procedural TIMI flow 0/1 compared with those without it (4.2% vs. 20.0%, P = 0.058). Patients with Wellens' sign were less likely to have left main and/or three-vessel disease (4.2% vs. 20.4%, P = 0.057). The rate of non-obstructive CAD was comparable between the two groups (25.0% vs. 21.6%, P = 0.70).

###### Angiographic Characteristics and In-Hospital Clinical Outcomes of Patients With and Without Wellens' Sign

                                                               Wellens' sign (n = 24)   Control (n = 250)    P value
  ------------------------------------------------------------ ------------------------ -------------------- ----------
  Angiographic findings                                                                                      
    Interval to angiography from presentation (day)            0.99 (0.31 - 1.63)       1.09 (0.60 - 1.95)   0.38
    Early invasive strategy within 24 h                        13 (54.2)                114 (45.6)           0.42
    Non-obstructive coronary artery disease                    6 (25.0)                 54 (21.6)            0.7
    Multi-vessel disease                                       7 (29.2)                 122 (48.8)           0.066
    Three-vessel disease                                       1 (4.2)                  45 (18.0)            0.093
    Left main disease                                          0 (0.0)                  12 (4.8)             0.61
    Left main and/or three-vessel disease                      1 (4.2)                  51 (20.4)            0.057
    Left anterior descending artery disease (stenosis ≥ 70%)   16 (66.7)                130 (52.0)           0.17
    Left anterior descending artery culprit                    16 (66.7)                49 (19.6)            \< 0.001
    Proximal left anterior descending artery culprit           8 (33.3)                 36 (14.4)            0.035
    Mid left anterior descending artery culprit                8 (33.3)                 13 (5.2)             \< 0.001
    Left circumflex artery disease (stenosis ≥ 70%)            5 (20.8)                 109 (43.6)           0.031
    Left circumflex artery culprit                             2 (8.3)                  58 (23.2)            0.093
    Right coronary artery disease (stenosis ≥ 70%)             5 (20.8)                 117 (46.8)           0.014
    Right coronary artery culprit                              0 (0.0)                  65 (26.0)            0.004
  Pre-procedural thrombolysis in myocardial infarction flow                                                  
    0/1                                                        1 (4.2)                  50 (20.0)            0.058
    2/3                                                        23 (95.8)                200 (80.0)           0.058
  In-hospital procedure                                                                                      
    In-hospital percutaneous coronary intervention             16 (66.7)                159 (63.6)           0.77
    In-hospital coronary artery bypass grafting                1 (4.2)                  18 (7.2)             1
    Intra-aortic balloon pump                                  1 (4.2)                  4 (16)               0.37
    Intubation                                                 1 (4.2)                  2 (0.8)              0.24
  In-hospital outcomes                                                                                       
    All-cause mortality                                        0 (0.0)                  1 (0.4)              1
    Recurrent myocardial infarction                            0 (0.0)                  1 (0.4)              1

Data are expressed as a number (percent) or median (interquartile range).

The rates of revascularization procedures such as PCI and CABG are comparable between patients with or without Wellens' sign. Except for one patient with three-vessel disease who underwent CABG, all of the patients with Wellens' sign and LAD culprit received PCI to LAD during the index admission.

Endpoints {#s3d}
---------

In-hospital clinical outcomes are summarized in [Table 4](#T4){ref-type="table"}. In our cohort of patients with NSTEMI, one patient died during the index admission and one patient suffered from recurrent myocardial infarction. The rate of in-hospital mortality and recurrent myocardial infarction were similar between the two groups.

Discussion {#s4}
==========

Our study revealed that: 1) Wellens' sign, defined as the presence of either symmetrically inverted T waves (≥ 0.10 mV) or biphasic T waves in both leads V2 and V3, was seen in 8.8% of the patients with NSTEMI; 2) Two-thirds of the NSTEMI patients with Wellens' sign had LAD culprit lesion and one-third had proximal LAD culprit lesion; and 3) Sensitivity and specificity of Wellens' sign to predict LAD culprit lesion were 24.6% and 96.2%, respectively.

More than 3 decades ago, de Zwaan et al were the first to describe symmetrically inverted or biphasic T waves in precordial leads in patients with unstable angina, which later became to be known as Wellens' sign \[[@R03]\]. In their study, 17.9% of the patients with unstable angina had this electrocardiographic finding. Among the patients with Wellens' sign who underwent coronary angiography, 69.2% of them had either total occlusion or high-grade stenosis in proximal LAD. During the index admission, 75.0% of the patients with Wellens' sign who did not undergo coronary angiography developed extensive anterior wall myocardial infarction. Subsequently, de Zwaan et al re-evaluated Wellens' sign in a large cohort of 1,260 patients with unstable angina and reported the prevalence of Wellens' sign as 16.2% \[[@R04]\]. Coronary angiography was performed in 88.2% of the patients with Wellens' sign and 29% of the patients with Wellens' sign had either total occlusion or high-grade stenosis of proximal LAD. Among patients with Wellens' sign who did not undergo early revascularization, 30.3% of them developed acute myocardial infarction during follow-up, suggesting that Wellens' sign identifies high-risk patients with impending LAD occlusion \[[@R03], [@R04]\].

These pioneer studies were performed before the wide-spread use of sensitive biomarker cardiac troponin \[[@R05]\] and it can be assumed that some of the unstable angina patients in these studies would have been diagnosed with NSTEMI if cardiac troponin had been available. The clinical implication of Wellens' sign in a contemporary NSTEMI cohort has not been evaluated. Our study revealed that Wellens' sign was seen in 8.8% of NSTEMI patients and that 66.7% of the patients with Wellens' sign had LAD culprit lesion and 33.3% of those had proximal LAD culprit, which was consistent with the result of prior study \[[@R04]\]. The presence of Wellens' sign had a predictive value for LAD culprit with a sensitivity of 24.6% and a specificity of 96.2%. Notably, despite its high specificity of Wellens' sign for LAD lesion, it was also observed in patients with non-LAD culprit lesions and non-obstructive CAD. It has been reported that Wellens' sign can be seen in a patient with normal coronary artery, mitral valve prolapse, and Prinzmetal's angina \[[@R03]\].

Although the exact mechanism of Wellens' sign has not been fully understood, a probable explanation is a brief transient episode of myocardial ischemia \[[@R04]\]. It has been reported that, during an attack of chest pain, patients with Wellens' sign lose their characteristic T-wave abnormalities or develop ST-segment elevation \[[@R04]\]. In our present study, almost all patients with Wellens' sign had pre-procedural TIMI flow 2 or 3. This suggests that Wellens' sign represents impending but canalized LAD culprit lesion in patients with NSTEMI.

In our present study, we chose cut-off of ≥ 0.10 mV for symmetrically inverted T waves. This is because as the cut-off of T-wave inversion increases, a sensitivity for LAD culprit falls to 9.2% for T-wave inversion (≥ 0.20 mV) and 3.1% for T-wave inversion (≥ 0.30 mV) with a similar specificity of 97.6% for T-wave inversion (≥ 0.20 mV) and 99.0% for T-wave inversion (≥ 0.30 mV). In addition, it was reported that the depth of inverted T waves did not carry a prognostic significance in de Zwaan' study \[[@R03]\].

This study has several limitations, including a retrospective design, a relatively small number of patients, and the lack of data on long-term clinical outcomes. We only included patients who underwent coronary angiography, and thus generalizability of our findings is limited. In addition, since follow-up electrocardiograms were available in a limited number of patients, we do not know if Wellens' sign improved after revascularization. However, prior studies demonstrated the resolution of those T-wave abnormalities after revascularization \[[@R03], [@R04]\]. Finally, the prognostic value of Wellens' sign for predicting short- and long-term outcomes is subject to further studies in larger cohorts.

Conclusions {#s4a}
-----------

The present study demonstrated that Wellens' sign was seen in 8.8% patients with NSTEMI. Two-thirds of the NSTEMI patients with Wellens' sign had LAD culprit lesion and one-third had proximal LAD culprit lesion. Wellens' sign had a predictive value for LAD culprit with a sensitivity of 24.6% and a specificity of 96.2%.
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